Cargando…
Melanoma brain metastases: review of histopathological features and immune-molecular aspects
Patients with melanoma brain metastases (MBM) have a dismal prognosis, but the unprecedented advances in systemic therapy alone or in combination with local therapy have now extended the 1-year overall survival rate from 20–25% to nearing 80–85%, mainly in asymptomatic patients. The histopathologica...
Autores principales: | Salvati, Lorenzo, Mandalà, Mario, Massi, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426753/ https://www.ncbi.nlm.nih.gov/pubmed/32821376 http://dx.doi.org/10.2217/mmt-2019-0021 |
Ejemplares similares
-
Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review
por: Indini, Alice, et al.
Publicado: (2021) -
Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?
por: Indini, Alice, et al.
Publicado: (2021) -
Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases
por: Fischer, Grant M, et al.
Publicado: (2021) -
Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications
por: Indini, Alice, et al.
Publicado: (2021) -
The Management of Brain Metastases—Systematic Review of Neurosurgical Aspects
por: Proescholdt, Martin A., et al.
Publicado: (2021)